{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:26:13Z","timestamp":1791177973699,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2500,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/ki.2008.624","type":"journal-article","created":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T11:00:35Z","timestamp":1233313235000},"page":"S62-S66","source":"Crossref","is-referenced-by-count":77,"special_numbering":"S112","title":["Treatment options for HUS secondary to Escherichia coli O157:H7"],"prefix":"10.1016","volume":"75","author":[{"given":"Martin","family":"Bitzan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2008.624_bb0010","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"10.1038\/ki.2008.624_bb0015","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1542\/peds.2005-0785","article-title":"Predictors of fatality in postdiarrheal hemolytic uremic syndrome","volume":"117","author":"Oakes","year":"2006","journal-title":"Pediatrics"},{"key":"10.1038\/ki.2008.624_bb0020","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s00467-005-1843-7","article-title":"Prospective surveillance of Canadian children with the haemolytic uraemic syndrome","volume":"20","author":"Proulx","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2008.624_bb0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1128\/JCM.42.1.311-319.2004","article-title":"Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999","volume":"42","author":"Blanco","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1038\/ki.2008.624_bb0030","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1532-5415.2006.00682.x","article-title":"Escherichia coli O157:H7 infection in nursing homes: review of literature and report of recent outbreak","volume":"54","author":"Reiss","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1038\/ki.2008.624_bb0035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S0950268804001979","article-title":"Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157","volume":"132","author":"Havelaar","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1038\/ki.2008.624_bb0040","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4315\/0362-028X-68.12.2623","article-title":"Economic cost of illness due to Escherichia coli O157 infections in the United States","volume":"68","author":"Frenzen","year":"2005","journal-title":"J Food Prot"},{"key":"10.1038\/ki.2008.624_bb0045","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF00867477","article-title":"Hemolytic uremic syndrome in children in northern India","volume":"5","author":"Srivastava","year":"1991","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2008.624_bb0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mop.0000152997.66070.e9","article-title":"Hemolytic uremic syndrome; pathogenesis, treatment, and outcome","volume":"17","author":"Siegler","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"10.1038\/ki.2008.624_bb0055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2215\/CJN.04961107","article-title":"Epidemiology of acute kidney injury","volume":"3","author":"Cerda","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.624_bb0060","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3201\/eid1405.071050","article-title":"Risk factors for sporadic Shiga toxin-producing Escherichia coli infections in children, Argentina","volume":"14","author":"Rivas","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1038\/ki.2008.624_bb0065","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1586\/14787210.5.4.653","article-title":"Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome","volume":"5","author":"Goldwater","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1038\/ki.2008.624_bb0070","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/jcp.21456","article-title":"Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies","volume":"216","author":"Tam","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1038\/ki.2008.624_bb0075","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1172\/JCI522","article-title":"Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium","volume":"101","author":"Bitzan","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2008.624_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1189\/jlb.71.1.107","article-title":"Shiga toxin 1-induced activation of c-Jun NH(2)-terminal kinase and p38 in the human monocytic cell line THP-1: possible involvement in the production of TNF-alpha","volume":"71","author":"Foster","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1038\/ki.2008.624_bb0085","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1462-5822.2007.01083.x","article-title":"Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells","volume":"10","author":"Lee","year":"2008","journal-title":"Cell Microbiol"},{"key":"10.1038\/ki.2008.624_bb0090","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0046-8177(88)80093-5","article-title":"The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections","volume":"19","author":"Richardson","year":"1988","journal-title":"Hum Pathol"},{"key":"10.1038\/ki.2008.624_bb0095","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/IAI.66.2.636-644.1998","article-title":"Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies","volume":"66","author":"Karpman","year":"1998","journal-title":"Infect Immun"},{"key":"10.1038\/ki.2008.624_bb0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa011033","article-title":"Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome","volume":"346","author":"Chandler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.624_bb0105","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00041552-199907000-00010","article-title":"The pathophysiology of the hemolytic uremic syndrome","volume":"8","author":"Andreoli","year":"1999","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.2008.624_bb0110","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF00857676","article-title":"Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes","volume":"4","author":"Kaplan","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2008.624_bb0115","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1542\/peds.2004-2236","article-title":"Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion","volume":"115","author":"Ake","year":"2005","journal-title":"Pediatrics"},{"key":"10.1038\/ki.2008.624_bb0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00467-007-0636-6","article-title":"Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression","volume":"23","author":"Nestoridi","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2008.624_bb0125","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ki.1997.170","article-title":"Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells","volume":"51","author":"van Setten","year":"1997","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.624_bb0130","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1097\/01.ASN.0000138547.51867.43","article-title":"Verotoxin (shiga toxin) sensitizes renal epithelial cells to increased heme toxicity: possible implications for the hemolytic uremic syndrome","volume":"15","author":"Bitzan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.624_bb0135","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1128\/IAI.73.11.7099-7106.2005","article-title":"Shiga toxin 1 causes direct renal injury in rats","volume":"73","author":"Yamamoto","year":"2005","journal-title":"Infect Immun"},{"key":"10.1038\/ki.2008.624_bb0140","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1067\/mpd.2002.125908","article-title":"Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study","volume":"141","author":"Klein","year":"2002","journal-title":"J Pediatr"},{"key":"10.1038\/ki.2008.624_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s004670050267","article-title":"Cardiomyopathy: a late complication of hemolytic uremic syndrome","volume":"11","author":"Walker","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2008.624_bb0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/341940","article-title":"Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997\u20132000, in Germany and Austria: a prospective study","volume":"186","author":"Gerber","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1038\/ki.2008.624_bb0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1159\/000080643","article-title":"Pulmonary hemorrhage complicating a typical hemolytic-uremic syndrome","volume":"71","author":"Piastra","year":"2004","journal-title":"Respiration"},{"key":"10.1038\/ki.2008.624_bb0160","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.2337\/diacare.28.10.2556","article-title":"Diabetes during diarrhea-associated hemolytic uremic syndrome: a systematic review and meta-analysis","volume":"28","author":"Suri","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2008.624_bb0165","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/jama.290.10.1337","article-title":"Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial","volume":"290","author":"Trachtman","year":"2003","journal-title":"JAMA"},{"key":"10.1038\/ki.2008.624_bb0170","first-page":"768","article-title":"Continuous hemofiltration in patients with abdominal complications of hemolytic uremic syndrome","volume":"130","author":"Cavagnaro","year":"2002","journal-title":"Rev Med Chil"},{"key":"10.1038\/ki.2008.624_bb0175","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0140-6736(99)01251-9","article-title":"Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak","volume":"354","author":"Dundas","year":"1999","journal-title":"Lancet"},{"key":"10.1038\/ki.2008.624_bb0180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2006-939766","article-title":"New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome","volume":"32","author":"Karch","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1038\/ki.2008.624_bb0185","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1086\/587670","article-title":"Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key","volume":"46","author":"Werber","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1038\/ki.2008.624_bb0190","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1086\/499236","article-title":"Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh","volume":"42","author":"Bennish","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1038\/ki.2008.624_bb0195","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1128\/JB.00069-08","article-title":"The CI repressors of Shiga toxin-converting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin 2","volume":"190","author":"Serra-Moreno","year":"2008","journal-title":"J Bacteriol"},{"key":"10.1038\/ki.2008.624_bb0200","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/315239","article-title":"Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice","volume":"181","author":"Zhang","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1038\/ki.2008.624_bb0205","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","article-title":"The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections","volume":"342","author":"Wong","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.624_bb0210","first-page":"357","article-title":"Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection","volume":"52","author":"Ikeda","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2008.624_bb0215","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3201\/eid1306.061264","article-title":"Strategies to reduce person-to-person transmission during widespread Escherichia coli O157:H7 outbreak","volume":"13","author":"Seto","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1038\/ki.2008.624_bb0220","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/373996","article-title":"Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands","volume":"187","author":"Mulvey","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1038\/ki.2008.624_bb0225","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/381130","article-title":"Prospects for preventing serious systemic toxemic complications of Shiga toxin-producing Escherichia coli infections using Shiga toxin receptor analogues","volume":"189","author":"Karmali","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1038\/ki.2008.624_bb0230","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1096\/fj.06-6572fje","article-title":"A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin","volume":"20","author":"Nishikawa","year":"2006","journal-title":"Faseb J"},{"key":"10.1038\/ki.2008.624_bb0235","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/323082","article-title":"Efficacy of postinfection treatment with anti-Shiga toxin (Stx) 2 humanized monoclonal antibody TMA-15 in mice lethally challenged with Stx-producing Escherichia coli","volume":"184","author":"Yamagami","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1038\/ki.2008.624_bb0240","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1128\/IAI.73.8.4607-4613.2005","article-title":"Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications","volume":"73","author":"Sheoran","year":"2005","journal-title":"Infect Immun"},{"key":"10.1038\/ki.2008.624_bb0245","first-page":"160A","article-title":"Shiga toxin causes Bcl-2 phosphorylation and apoptosis of renal epithelial cells via c-Jun kinase","volume":"16","author":"Bitzan","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.624_bb0250","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1189\/jlb.0605313","article-title":"Shiga toxin 1-induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage-like THP-1 cell line","volume":"79","author":"Cherla","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1038\/ki.2008.624_bb0255","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1462-5822.2008.01139.x","article-title":"ZAK: a MAP3Kinase that transduces Shiga toxin- and ricin-induced proinflammatory cytokine expression","volume":"10","author":"Jandhyala","year":"2008","journal-title":"Cell Microbiol"},{"key":"10.1038\/ki.2008.624_bb0260","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00467-004-1502-4","article-title":"Role of p38 MAP kinase pathway in a toxin-induced model of hemolytic uremic syndrome","volume":"19","author":"Fu","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2008.624_bb0265","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1538-7836.2005.01205.x","article-title":"Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome","volume":"3","author":"Nestoridi","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1038\/ki.2008.624_bb0270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/153685902760173872","article-title":"Development of humanized monoclonal antibody TMA-15 which neutralizes Shiga toxin 2","volume":"21","author":"Kimura","year":"2002","journal-title":"Hybrid Hybridomics"},{"key":"10.1038\/ki.2008.624_bb0275","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/CMR.17.4.926-941.2004","article-title":"Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome","volume":"17","author":"Tzipori","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1038\/ki.2008.624_bb0280","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1128\/AAC.49.5.1808-1812.2005","article-title":"Phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody c alpha Stx2 administered intravenously to healthy adult volunteers","volume":"49","author":"Dowling","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1038\/ki.2008.624_bb0285","first-page":"473","article-title":"Anti Shiga-like toxin II(SLT-II) humanized monoclonal antibody","volume":"60","author":"Matsumoto","year":"2002","journal-title":"Nippon Rinsho"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381553620X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381553620X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T20:21:51Z","timestamp":1710015711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381553620X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":56,"alternative-id":["S008525381553620X"],"URL":"https:\/\/doi.org\/10.1038\/ki.2008.624","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}